Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Global Clean Energy ETF (ICLN) vs Nuwellis Inc (NUWE) Price & Performance

iShares Global Clean Energy ETFTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

iShares Global Clean Energy ETF vs Nuwellis Inc — how do they compare? iShares Global Clean Energy ETF trades at $18.38, while Nuwellis Inc trades at $1.48 (market cap $542.80K). The key difference: iShares Global Clean Energy ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

ICLNNUWE
52-Week High
$23.75$220.50
52-Week Low
$13.66$1.42
Market Cap
$542.80K
Sector
Technology
Enterprise Value
-$1.27M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Global Clean Energy ETF

No Aura AI signal available yet.

Nuwellis Inc

NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.

The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.

Returns comparison

Trailing returns across standard periods

About iShares Global Clean Energy ETF

The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.

Read more on ICLN

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE